An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation

An aerosol formulation containing 7.5 mg of R-salbutamol sulfate was developed. The aerosol was nebulized with an air-jet nebulizer, and further assessed according to the new European Medicines Agency (EMA) guidelines. A breath simulator was used for studies of delivery rate and total amount of the...

Full description

Bibliographic Details
Main Authors: Xuemei Zhang, Qing Liu, Junhua Hu, Ling Xu, Wen Tan
Format: Article
Language:English
Published: Elsevier 2014-02-01
Series:Acta Pharmaceutica Sinica B
Subjects:
NGI
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383513001159